β-MSH (beta-melanocyte-stimulating hormone): the POMC peptide tied to human appetite

The verse of the system that speaks loudest in humans — a melanocortin the mouse mostly skips, and a reminder the map is redrawn in people.

β-MSH — beta-melanocyte-stimulating hormone — is one of the quieter members of the melanocortin family, but it carries an outsized lesson about why this system matters in people specifically. Like α-MSH, it is a broad-spectrum agonist cut from POMC. Unlike α-MSH, its story is largely a human one, because the animals most of melanocortin science has been done in cannot make it at all.^[3]

Where it comes from: the lipotropin branch

POMC is a prohormone cut into pieces at pairs of basic amino acids by the prohormone convertases PC1/3 and PC2, and the pieces it yields depend on which enzymes a tissue carries.^[2] The first cuts release an N-terminal fragment, ACTH, and β-lipotropin. α-MSH is then carved from within ACTH. β-MSH comes from the other end of the molecule: in tissues that express PC2 — the hypothalamus, the skin and the pituitary's intermediate lobe — β-lipotropin is cut into γ-lipotropin and β-endorphin, and γ-lipotropin is cut again to release β-MSH, a 22-amino-acid peptide in humans that carries the family's shared His-Phe-Arg-Trp core.^[2][8] It is, in other words, made by the same enzyme and in the same neurons as α-MSH, as a parallel product of the same precursor.

The cut the mouse cannot make

What makes β-MSH worth its own page is a quirk of sequence. The final cut that frees β-MSH from γ-lipotropin requires a pair of basic residues at the right spot, and rodent POMC does not have it. In mice and rats, processing stops at γ-lipotropin, and no β-MSH is ever produced.^[1][3] Humans, other primates and dogs carry the site and make the peptide. The consequence is easy to overlook and important to remember: a satiety signal that is real in people is absent from the standard animal model. Mice get by perfectly well with α-MSH alone, which tells us α-MSH is sufficient for the circuit — but not that it is the whole of the circuit in us.^[3]

A second key for the appetite receptor

At the receptor that matters most for body weight, β-MSH is not a weaker copy of α-MSH. It binds MC4R with affinity at least equal to α-MSH's, and when given into the brain of rats it suppresses feeding — the rat, lacking its own β-MSH, has no trouble reading it.^[1] Harrold and colleagues argued in 2003 that β-MSH might be the more important natural MC4R ligand in the human hypothalamus, where both peptides are made side by side.^[1] That remains a hypothesis rather than a settled fact, because the two peptides cannot be separated in a living human brain; what is settled is that β-MSH is a genuine part of the human melanocortin "fullness" signal, and the genetics that followed made that concrete.

A variant in the β-MSH sequence

In 2006 two groups, publishing back to back, reported the same rare POMC variant: a tyrosine-to-cysteine change, Tyr221Cys, that falls inside the β-MSH sequence and leaves every other POMC product untouched. Among obese children in the United Kingdom the variant was found far more often than in the general population; the children carrying it were hyperphagic and unusually tall for their age, the same pattern seen when MC4R itself is impaired. In the laboratory, the variant peptide bound MC4R less well and activated it less strongly than normal β-MSH.^[4] The second study, in German children, reached the same conclusion and showed that the variant peptide could not match the natural one in switching the receptor on.^[5] A single amino acid, in a peptide mice do not make, was enough to tilt human energy balance — and it did so by weakening one ligand's grip on MC4R while α-MSH was left intact.

The dog that proved the point

The most vivid evidence for what β-MSH does comes from an animal that, like us, makes it. In 2016 a 14-base-pair deletion was found in the POMC gene of Labrador and flat-coated retrievers, breeds notorious for their appetite. The deletion disrupts the end of the gene so that β-MSH and β-endorphin cannot be produced, and dogs carrying it were heavier, had more body fat and scored higher on food motivation; it was also more common in Labradors working as assistance dogs, where a strong food drive helps training.^[6] A follow-up in 2024 showed what the missing peptides had been doing. Dogs with the deletion had a resting metabolic rate about a quarter lower than unaffected dogs and were hungrier between meals, although they did not eat faster or more at a sitting: the deletion lowered how much energy the body spends and raised the drive to seek food, the two levers the melanocortin system is known to hold.^[7]It is as close to a natural knockout of β-MSH as exists, and it was found in a species that has the peptide to lose.

Why the mouse data need a translation step

All of this feeds one practical lesson. POMC-neuron biology, MC4R pharmacology and most of the appetite story on this site were worked out in mice, and in mice the entire melanocortin satiety signal is α-MSH. In humans it is α-MSH and β-MSH together, read by the same receptor. Where that matters is at the edges: in interpreting human POMC variants, where a change in the β-MSH region can have effects no mouse would show; in understanding why POMC-processing enzyme deficiencies look the way they do in people;^[3] and in reading any claim about a melanocortin ligand's human relevance that rests on rodent data alone. The receptors are shared. The set of natural keys is not.

The honest bottom line

β-MSH is a reminder that the melanocortin system is not identical from one species to the next. Its broad receptor activity makes it look like a second α-MSH, but its human-specific role in appetite gives it a distinct place in the story, confirmed by genetics in two species — and a cautionary note for anyone reading mouse data as if it were human data. For the receptor at the centre of that appetite signalling, see MC4R — the appetite rheostat; for the drug that re-supplies the signal β-MSH and α-MSH share, see setmelanotide.